Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.6 EUR | +0.72% | -6.20% | +30.84% |
04-17 | OSE: licensing agreement with AbbVie enters into force | CF |
04-17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- Other languages